Highly rated in
Highly rated in
Areas of Expertise
Check Dr. Peter Kabos' experience treating your condition:
About Dr. Peter Kabos

Peter Kabos is an Oncologist and a Hematologist Oncology expert in Aurora, Colorado. Kabos has been practicing medicine for over 25 years and is highly rated in 7 conditions, according to our data. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Gamma Knife Radiosurgery. He is licensed to treat patients in Colorado. Kabos is currently accepting new patients.

His clinical research consists of co-authoring 64 peer reviewed articles and participating in 6 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Peter Kabos it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Peter Kabos accepts the following insurance:

  •  Ambetter
  •  Bright Health
  •  Medica

Call to see if your plan is accepted.
1665 Aurora Ct, Aurora, CO 80045
Other Locations
12605 E 16th Ave, Aurora, CO 80045
Background & Education
Graduate Institution
Other, 1998
Hematology Oncology
Internal Medicine in CO
Hospital Affiliations
UCHealth Poudre Valley Hospital
UCHealth University Of Colorado Hospital
Community Medical Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized Phase II Trial Of Circulating Tumor DNA-Guided Second Line Adjuvant Therapy For High Residual Risk, Stage II-III, Hormone Receptor Positive, HER2 Negative Breast Cancer
Multicenter Open Label Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer
A Phase 1b Study of Abemaciclib in Combination With Pembrolizumab for Patients With Stage IV Non-Small Cell Lung Cancer or Hormone Receptor Positive, HER2 Negative Breast Cancer
A Single Arm Phase II Study to Evaluate Efficacy of T-DM1 With Palbociclib in the Treatment of Patients With Metastatic HER2 Positive Breast Cancer
View 4 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors